233 related articles for article (PubMed ID: 24144083)
21. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
22. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
23. Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation.
Tal R; Seifer DB; Grazi RV; Malter HE
Reprod Biol Endocrinol; 2014 Aug; 12():82. PubMed ID: 25141961
[TBL] [Abstract][Full Text] [Related]
24. Serum resistin and adiponectin levels in women with polycystic ovary syndrome.
Yilmaz M; Bukan N; Demirci H; Oztürk C; Kan E; Ayvaz G; Arslan M
Gynecol Endocrinol; 2009 Apr; 25(4):246-52. PubMed ID: 19408174
[TBL] [Abstract][Full Text] [Related]
25. Serum and follicular fluid levels of soluble receptor for advanced glycation end-products in women with and without polycystic ovary syndrome.
Emami N; Alizadeh A; Maleki-Hajiagha A; Dizavi A; Vesali S; Moini A
J Ovarian Res; 2023 Jun; 16(1):127. PubMed ID: 37391740
[TBL] [Abstract][Full Text] [Related]
26. Pioglitazone is effective for multiple phenotyepes of the Zucker fa/fa rat with polycystc ovary morphology and insulin resistance.
Morishita M; Endo T; Baba T; Kuno Y; Ikeda K; Kiya T; Honnma H; Saito T
J Ovarian Res; 2018 Mar; 11(1):24. PubMed ID: 29580285
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the Relationship Between Serum High Molecular Weight Adiponectin Hormone Levels and Insulin Resistance in Patients with Polycystic Ovary Syndrome.
Pekcan MK; Tokmak A; Akkaya H; Pekcan G; Onur A; Kısa Ü; Çil AP
Horm Metab Res; 2019 Apr; 51(4):261-266. PubMed ID: 31022741
[TBL] [Abstract][Full Text] [Related]
28. Hyper response to ovarian stimulation affects the follicular fluid metabolomic profile of women undergoing IVF similarly to polycystic ovary syndrome.
Cordeiro FB; Cataldi TR; de Souza BZ; Rochetti RC; Fraietta R; Labate CA; Lo Turco EG
Metabolomics; 2018 Mar; 14(4):51. PubMed ID: 30830356
[TBL] [Abstract][Full Text] [Related]
29. Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles.
Seow KM; Juan CC; Hsu YP; Ho LT; Wang YY; Hwang JL
Hum Reprod; 2005 Jan; 20(1):117-21. PubMed ID: 15513972
[TBL] [Abstract][Full Text] [Related]
30. Proteomic profile of follicular fluid from patients with polycystic ovary syndrome (PCOS) submitted to in vitro fertilization (IVF) compared to oocyte donors.
Domingues TS; Bonetti TC; Pimenta DC; Mariano DOC; Barros B; Aquino AP; Motta ELA
JBRA Assist Reprod; 2019 Oct; 23(4):367-391. PubMed ID: 31173497
[TBL] [Abstract][Full Text] [Related]
31. Serum and follicular fluid irisin levels in poor and high responder women undergoing IVF/ICSI.
Acet M; Celik N; Acet T; Ilhan S; Yardim M; Aktun HL; Basaranoglu S; Deregozu A; Aydin S
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):1940-6. PubMed ID: 27249590
[TBL] [Abstract][Full Text] [Related]
32. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome.
Gupta V; Mishra S; Mishra S; Gupta V
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S697-S701. PubMed ID: 28529126
[TBL] [Abstract][Full Text] [Related]
33. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome.
Lauria PB; Del Puerto HL; Reis AM; Candido AL; Reis FM
J Clin Endocrinol Metab; 2013 Dec; 98(12):4882-9. PubMed ID: 24057296
[TBL] [Abstract][Full Text] [Related]
34. Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome.
Glintborg D; Frystyk J; Højlund K; Andersen KK; Henriksen JE; Hermann AP; Hagen C; Flyvbjerg A; Andersen M
Clin Endocrinol (Oxf); 2008 Feb; 68(2):165-74. PubMed ID: 17803698
[TBL] [Abstract][Full Text] [Related]
35. Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome.
Gulcelik NE; Aral Y; Serter R; Demir Y; Culha C
Gynecol Endocrinol; 2006 Sep; 22(9):511-5. PubMed ID: 17071536
[TBL] [Abstract][Full Text] [Related]
36. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
37. Elevated ovarian pentraxin 3 in polycystic ovary syndrome.
Pan J; Zhou C; Zhou Z; Yang Z; Dai T; Huang H; Jin L
J Assist Reprod Genet; 2021 May; 38(5):1231-1237. PubMed ID: 33594624
[TBL] [Abstract][Full Text] [Related]
38. The role of serum adiponectin levels in women with polycystic ovarian syndrome.
Itoh H; Kawano Y; Furukawa Y; Matsumoto H; Yuge A; Narahara H
Clin Exp Obstet Gynecol; 2013; 40(4):531-5. PubMed ID: 24597249
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition.
Barber TM; Hazell M; Christodoulides C; Golding SJ; Alvey C; Burling K; Vidal-Puig A; Groome NP; Wass JA; Franks S; McCarthy MI
J Clin Endocrinol Metab; 2008 Jul; 93(7):2859-65. PubMed ID: 18445670
[TBL] [Abstract][Full Text] [Related]
40. Adiponectin isoform distribution in serum and in follicular fluid of women undergoing treatment by ICSI.
Bersinger NA; Wunder DM
Acta Obstet Gynecol Scand; 2010 Jun; 89(6):782-8. PubMed ID: 20504081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
